Relay Therapeutics Inc
NASDAQ:RLAY

Watchlist Manager
Relay Therapeutics Inc Logo
Relay Therapeutics Inc
NASDAQ:RLAY
Watchlist
Price: 8.46 USD 1.32% Market Closed
Market Cap: 1.5B USD

Wall Street
Price Targets

RLAY Price Targets Summary
Relay Therapeutics Inc

Wall Street analysts forecast RLAY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RLAY is 14.89 USD with a low forecast of 12.12 USD and a high forecast of 19.95 USD.

Lowest
Price Target
12.12 USD
43% Upside
Average
Price Target
14.89 USD
76% Upside
Highest
Price Target
19.95 USD
136% Upside
Relay Therapeutics Inc Competitors:
Price Targets
9926
Akeso Inc
53% Upside
FDMT
4D Molecular Therapeutics Inc
350% Upside
ORKA
Oruka Therapeutics Inc
65% Upside
PEB
Pacific Edge Ltd
31% Downside
EVAX
Evaxion Biotech A/S
164% Upside
GNFT
Genfit SA
67% Upside
PHM
Pharma Mar SA
33% Upside
068270
Celltrion Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Relay Therapeutics Inc

The compound annual growth rate of Relay Therapeutics Inc's revenue for the next 4 years is -2%.

N/A
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Relay Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Relay Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLAY's stock price target?
Price Target
14.89 USD

According to Wall Street analysts, the average 1-year price target for RLAY is 14.89 USD with a low forecast of 12.12 USD and a high forecast of 19.95 USD.

What is Relay Therapeutics Inc's Revenue forecast?
Projected CAGR
-2%

The compound annual growth rate of Relay Therapeutics Inc's revenue for the next 4 years is -2%.

Back to Top